Trista Morrison
Ufficiale delle Risorse Umane presso VOYAGER THERAPEUTICS, INC.
Profilo
Trista Morrison is currently the Director at Network of Tyrosinemia Advocates, Inc. and the Chief of Staff & SVP Corporate Affairs at Voyager Therapeutics, Inc. She previously worked as the Director-Corporate Communications at Ironwood Pharmaceuticals, Inc., the Head-Media Relations at Gemin X Pharmaceuticals US, Inc., and the Chief Communications Officer at Saniona AB.
Ms. Morrison completed her undergraduate degree at Tulane University (Louisiana).
Posizioni attive di Trista Morrison
| Società | Posizione | Inizio |
|---|---|---|
| VOYAGER THERAPEUTICS, INC. | Ufficiale delle Risorse Umane | - |
| Network of Tyrosinemia Advocates, Inc. | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Trista Morrison
| Società | Posizione | Fine |
|---|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Public Communications Contact | - |
| SANA AB | Public Communications Contact | - |
Gemin X Pharmaceuticals US, Inc.
 Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Public Communications Contact | - |
Formazione di Trista Morrison
| Tulane University (Louisiana) | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| SANA AB | Health Technology |
| Aziende private | 2 |
|---|---|
Gemin X Pharmaceuticals US, Inc.
Gemin X Pharmaceuticals US, Inc. BiotechnologyHealth Technology Gemin X Pharmaceuticals US Inc. is engaged in the development of cancer therapeutics. It offers mimetic and telomere capping programs, as well as screening, medicinal chemistry, and preclinical development services. The company was founded by Gordon C. Shore in 1998 and is headquartered in Malvern, PA. | Health Technology |
| Network of Tyrosinemia Advocates, Inc. |
- Borsa valori
- Insiders
- Trista Morrison